RONAL RICANO: Open Payments
NPI 1356677371 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 62 payments from 15 companies in 2025. Trend: 2023 $647 · 2024 $1,197 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $371 |
| Phathom Pharmaceuticals, Inc. | 11 | $226 |
| Intercept Pharmaceuticals, Inc. | 4 | $107 |
| Ardelyx, Inc. | 5 | $83 |
| Lilly USA, LLC | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| GENZYME CORPORATION | 2 | $56 |
| Aimmune Therapeutics, Inc. | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $53 |
| VIVUS LLC | 2 | $41 |
Products named: LINZESS, VOQUEZNA, DUPIXENT, OCALIVA, IBSRELA, OMVOH, RINVOQ, ZENPEP.
Industry payments across FL — which companies pay providers there.
